Description
GS-967 inhibits voltage-gated Na+ channels, exhibiting antiepileptic, anticonvulsant, ant anti-arrhythmic activities. GS-967 decreases the cardiac late Na+ current. In vivo, this compound decreases seizure frequency and improves survival rates. In rat hearts, GS-967 suppresses and prevents ventricular tachycardia and fibrillation.